PMID: 9545017Apr 17, 1998Paper

Effects of sibutramine on resting metabolic rate and weight loss in overweight women

Obesity Research
H M SeagleJ O Hill

Abstract

Sibutramine, a monoamine re-uptake inhibitor, has recently been approved by the Food and Drug Administration as a weight loss agent. Sibutramine lowers bodyweight in rodents by reducing energy intake and increasing energy expenditure. Sibutramine facilitates weight loss in human subjects, but it is not clear whether it acts on energy intake, energy expenditure, or both. The present study was a randomized clinical trial designed to assess the effects of sibutramine (at 10 or 30 mg/day) on body weight and resting metabolic rate (RMR). Forty-four overweight women were randomized to 1) placebo (n=15); 2) sibutramine at 10 mg/day (n=15) or, 3) sibutramine at 30 mg/day (n=14). All subjects were instructed to consume a 1200 kcal/day diet for 8 weeks while receiving drug or placebo. RMR was assessed by indirect calorimetry at baseline, at 3 hours after the first dose of drug (or placebo), and at the end of the 8-week weight-loss period. Sibutramine reduced body weight-relative to placebo, but there was no difference between weight loss on the two sibutramine doses. No significant differences in RMR between sibutramine and placebo were seen, either 3-hour post dose or after the 8-week weight-loss period. After the weight loss period, al...Continue Reading

References

Aug 1, 1992·Psychological Medicine·M A DewL Penkower
Jan 1, 1992·The American Journal of Clinical Nutrition·D A Levitsky, R Troiano
Oct 1, 1991·Sports Medicine·J E DonnellyS Gunderson
Sep 1, 1991·Clinical Pharmacology and Therapeutics·M WeintraubM L Scheinbaum
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·W R BuckettG P Luscombe
Nov 1, 1988·British Journal of Clinical Pharmacology·D J King, N Devaney
Jul 1, 1969·Journal of Applied Physiology·J H Wilmore
Apr 1, 1995·The Journal of Surgical Research·M M MeguidJ R Gleason
Dec 1, 1993·Research Quarterly for Exercise and Sport·S N Blair
Aug 1, 1993·American Journal of Diseases of Children·J F SallisJ E Alcaraz
May 1, 1996·Obesity Research·G A BrayK Wilson
Sep 26, 1963·Annals of the New York Academy of Sciences·J BROZEKA KEYS

❮ Previous
Next ❯

Citations

Oct 27, 1998·Journal of the American Dietetic Association·C A Nonas
May 15, 2002·European Journal of Pharmacology·Carla A Luque, Jose A Rey
Mar 15, 2003·Clinical Therapeutics·Wilson Y S LeungBrian Tomlinson
Apr 24, 2001·Pharmacology & Therapeutics·J C ClaphamM Tadayyon
Aug 4, 2012·Nature Reviews. Drug Discovery·Marcelo O Dietrich, Tamas L Horvath
Jul 28, 2001·Diabetes Technology & Therapeutics·F Greenway
Oct 7, 2006·Current Opinion in Gastroenterology·D H Ryan
Oct 13, 2006·Current Opinion in Gastroenterology·Robert F Kushner, Hazel Manzano
Apr 15, 2008·Annual Review of Nutrition·Mary-Ellen HarperMartin D Brand
Jan 31, 2008·Annals of Nutrition & Metabolism·Arie RotsteinNachum Vaisman
May 30, 2009·Vascular Health and Risk Management·Konstantinos TziomalosThemistoklis Tzotzas
Aug 1, 2007·Journal of Veterinary Pharmacology and Therapeutics·J GossellinS J Sunderland
Sep 19, 2009·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A Schwartz, E Doucet
Feb 14, 2006·Clinical Cornerstone·George L Blackburn, Belinda A Waltman
Oct 19, 2005·Appetite·Jason C G Halford
Jun 9, 2005·Journal of the American Dietetic Association·Roland N Dickerson, Lori Roth-Yousey
Jul 26, 2015·Metabolism: Clinical and Experimental·Tamás KitkaPéter Kovács
Apr 2, 1999·Obesity Research·G A BrayT B Seaton
Nov 26, 1999·Obesity Research·A TremblayD Richard
Mar 12, 2002·Obesity Research·Alison M StrackGerard J Hickey
Jun 11, 2002·Obesity Research·Suzanne Phelan, Thomas A Wadden
May 2, 2001·Obesity Research·R D StarlingD H Sullivan
Mar 11, 2009·São Paulo Medical Journal = Revista Paulista De Medicina·Hernani Pinto de LemosAndré Luis Alves de Lemos
May 10, 2007·Canadian Journal of Physiology and Pharmacology·Silvana Soriano FrassettoAnapaula Sommer Vinagre
Aug 30, 2008·Journal of Psychopharmacology·J C G HalfordJ P H Wilding
Apr 15, 2000·Nature·G A Bray, L A Tartaglia
Jul 31, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·S Bérubé-ParentA Tremblay
Nov 6, 2002·Circulation·Andreas L BirkenfeldJens Jordan
Jan 28, 2005·The Cochrane Database of Systematic Reviews·S L NorrisJ Lau
Aug 13, 2009·The British Journal of Nutrition·Jose E GalganiEric Ravussin
Apr 25, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·D HansenUNKNOWN STORM Study Group
Oct 30, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Enzo Nisoli, Michele O Carruba
Dec 22, 1999·Endocrine Reviews·G A Bray, F L Greenway
Aug 2, 2008·Expert Opinion on Pharmacotherapy·Bikash Sharma, David C Henderson
May 15, 2008·Current Sports Medicine Reports·David G CarfagnoLuke Knowlton
Jun 2, 2007·Pharmacological Reviews·George A Bray, Frank L Greenway
Mar 1, 2003·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A Halpern, M C Mancini
Sep 24, 1999·The Annals of Pharmacotherapy·C A Luque, J A Rey
Nov 18, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·B E Levin, A A Dunn-Meynell
Mar 12, 2004·Expert Opinion on Pharmacotherapy·Walker S Carlos Poston, John P Foreyt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
K M WalshM E Lean
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
D L HansenA Astrup
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
E Danforth
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
C HanotinP Drouin
© 2022 Meta ULC. All rights reserved